157 related articles for article (PubMed ID: 36135042)
21. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
Kim WY; Kim HY; Son GS; Bae JW; Lee JB
J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
[TBL] [Abstract][Full Text] [Related]
22. Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Zhou YL; Zhang W; Gao EL; Dai XX; Yang H; Zhang XH; Wang OC
Asian Pac J Cancer Prev; 2012; 13(4):1267-72. PubMed ID: 22799316
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Prognosis of Unilateral and Multifocal Papillary Thyroid Microcarcinoma After Unilateral Lobectomy Versus Total Thyroidectomy.
Jeon YW; Gwak HG; Lim ST; Schneider J; Suh YJ
Ann Surg Oncol; 2019 Sep; 26(9):2952-2958. PubMed ID: 31264119
[TBL] [Abstract][Full Text] [Related]
24. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
25. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
[TBL] [Abstract][Full Text] [Related]
26. Total thyroidectomy: safe and adequate treatment for papillary microcarcinoma of the thyroid gland.
Uhliarova B; Hajtman A
B-ENT; 2016 Aug; 12(2):119-124. PubMed ID: 29553616
[TBL] [Abstract][Full Text] [Related]
27. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
28. A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.
Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Song DE; Sung TY; Yoon JH; Hong SJ; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2017 Apr; 176(4):371-378. PubMed ID: 28089996
[TBL] [Abstract][Full Text] [Related]
29. Clinical impact of microscopic extrathyroidal extension in patients with papillary thyroid microcarcinoma treated with hemithyroidectomy.
Ahn D; Sohn JH; Jeon JH; Jeong JY
J Endocrinol Invest; 2014 Feb; 37(2):167-73. PubMed ID: 24497215
[TBL] [Abstract][Full Text] [Related]
30. Ultrasonography is valuable in evaluation of papillary thyroid microcarcinoma based on 5 mm tumor size.
Xia S; Dong Y; Kang H; Zhan W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S319-S323. PubMed ID: 29970683
[TBL] [Abstract][Full Text] [Related]
31. Papillary thyroid microcarcinoma: an over-treated malignancy?
Wang TS; Goffredo P; Sosa JA; Roman SA
World J Surg; 2014 Sep; 38(9):2297-303. PubMed ID: 24791670
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract][Full Text] [Related]
33. Quality of Life in Papillary Thyroid Microcarcinoma Patients Undergoing Radiofrequency Ablation or Surgery: A Comparative Study.
Lan Y; Luo Y; Zhang M; Jin Z; Xiao J; Yan L; Zhu Y
Front Endocrinol (Lausanne); 2020; 11():249. PubMed ID: 32499754
[No Abstract] [Full Text] [Related]
34. Clinicopathological Findings Associated With Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study in China.
Shi Y; Yang Z; Heng Y; Ju H; Pan Y; Zhang Y
Cancer Control; 2022; 29():10732748221084926. PubMed ID: 35285273
[TBL] [Abstract][Full Text] [Related]
35. [Managements of small thyroid nodules with contralateral papillary thyroid microcarcinoma].
Meng LW; Huang LM; Xu CY; Zhang W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):827-30. PubMed ID: 23302164
[TBL] [Abstract][Full Text] [Related]
36. Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.
Lombardi CP; Bellantone R; De Crea C; Paladino NC; Fadda G; Salvatori M; Raffaelli M
World J Surg; 2010 Jun; 34(6):1214-21. PubMed ID: 20052467
[TBL] [Abstract][Full Text] [Related]
37. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center.
Gui Z; Wang Z; Xiang J; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Qin Y; Zhang T; Shao L; Zhang P; Zhang H
Med Sci Monit; 2020 Dec; 26():e927407. PubMed ID: 33351790
[TBL] [Abstract][Full Text] [Related]
39. Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features.
Kim KE; Kim EK; Yoon JH; Han KH; Moon HJ; Kwak JY
World J Surg; 2013 Feb; 37(2):385-91. PubMed ID: 23073506
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
